跳至主要内容
临床试验/CTRI/2023/11/059696
CTRI/2023/11/059696尚未招募4 期

COMPARISON OF TREATMENT RESPONSE TO TOPICAL PROPOLIS FORTIFIED WITH VITAMINS VERSUS TRIAMCINOLONE ACETONIDE IN THE MANAGEMENT OF ORAL POTENTIALLY MALIGNANT DISORDERS AND ROLE OF ALPHA ENOLASE(ENO1) AND GALECTIN 9(GAL9) AS CRITICAL REGULATORS FOR ORAL POTENTIALLY MALIGNANT DISORDERS AND ORAL SQUAMOUS CELL CARCINOMA: A RANDOMIZED CONTROL CLINICAL TRIAL - NI

Maulana Azad Institute of Dental Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Clinically & histopathologically proven cases of OSMF and OLP and OSCC
  • Any subject of age group18 to 50 years.
  • Both males and females.
  • A positive history of chewing areca nut or one of its commercial preparation, difficulty in swallowing and chewing, and burning sensation on eating spicy foods.(osmf)
  • Restricted mouth opening and changes in the oral mucous membrane including the presence of palpable vertical fibrous bands, stiffness and blanching.(osmf)

排除标准

  • Subjects with mouth opening less than 15 mm.
  • Subjects with systemic diseases, immunocompromised patients and patients who are taking medications which may effect the result of the study.
  • Pregnant and nursing women.
  • Subjects who are known allergic to honey bees or bee products.
  • Those patients who are not willing to participate in study.

研究者

相似试验

COMPARISON OF TREATMENT RESPONSE TO TOPICAL PROPOLIS... | 临床试验